18 Jan 2023|Noida | Amity University, Noida
Amity Centre for Translational Research (ACTR) established at Amity, to facilitate Clinical Research to manage Lifestyle- associated Diseases
![]()
Amity University Uttar Pradesh has established the Amity Centre for Translational Research (ACTR) to facilitate clinical research for managing lifestyle associated diseases. The mission of Amity Centre for Translational Research (ACTR) is to identify treatment modalities for community-wide diseases that are currently prevalent and expected to rise due to changing lifestyle, including Latent Tuberculosis, Refractory Cancer, Chronic Inflammatory diseases such as Inflammatory Bowel diseases, amongst others. The Centre also aims to produce skilled manpower by offering Ph.D degree in Biomedical Sciences for taking up entrepreneur path in Clinical Research.
Expressing extreme pleasure on this occasion, Dr. Ashok K. Chauhan, Founder President, Amity Education Group, averred, “Amity is one of the leading institutions in the world, with a strong focus on research and innovation. With its commitment to nurture the world’s greatest scientists, Amity has established Amity Centre for Translational Research, which is a testimony to Amity’s commitment to contribute to the scientific development of the country and the world and support the government’s initiatives of “Atmnirbhar” and “Swasth Bharat.”
Highlighting the role of ACTR, Prof. (Dr.) Hridayesh Prakash, Professor & Assistant Director, Amity Centre for Translational Research, said, “The establishment of ACTR will help in the upliftment of the healthcare sector through conducting cutting-edge research at the clinical interface. In addition, the collaboration with various national and international R&D labs and hospitals will assist ACTR to conduct clinical studies which are important for validating new pharmaceuticals. Numerous idiopathic diseases occur in human beings as a result of urbanisation and the related changes in lifestyle. Understanding these disorders' complex biology is crucial for the health care system, however, human beings are still unsure of the precise sequence of events which cause healthy cells to become diseased. Several evidences suggest a crucial role of the microbiome's composition, combined with intrinsic molecular drivers or signals, in disease development. Next-Generation Sequencing (NGS) and other genomic technologies have assisted researchers in multifactorial analysis to comprehend the pathogenesis of complex diseases. These insights can help in the creation of pharmaceutics and effective drug discovery, wherein ACTR will play a significant role.”